Cetera Investment Advisers
BDSX icon

Cetera Investment Advisers’s Biodesix BDSX Stock Holding History

Cetera Investment Advisers’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-12,000
Closed -$174K – 5024
2026
Q1 		$174K Buy
12,000
+2,000
+20% +$24.8K ﹤0.01% 4322
2025
Q4 		$68K Buy
+10,000
New +$73.7K ﹤0.01% 4470
2025
Q3 		– Sell
-500
Closed -$2.82K – 4577
2025
Q2 		$2.82K Buy
+500
New +$4.04K ﹤0.01% 4067
2024
Q4 		– Sell
-3,900
Closed -$139K – 3790
2024
Q3 		$139K Hold
3,900
– – ﹤0.01% 3473
2024
Q2 		$119K Hold
3,900
– – ﹤0.01% 3481
2024
Q1 		$112K Buy
+3,900
New +$133K ﹤0.01% 3482

Other funds holding BDSX

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
TAM
Telemark Asset Management Boston, Massachusetts $1.38B AUM 71.45% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIM
Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Cetera Investment Advisers's BDSX Position: Q2 2026 in Review

Cetera Investment Advisers sold out of Biodesix (BDSX) in Q2 2026, closing a stake of 12,000 shares — an estimated $174K sold.

Cetera Investment Advisers first reported a position in BDSX in Q1 2024 and held it in 6 quarters. The position peaked at $174K in Q1 2026. 45 funds tracked by Wall St. Rank hold BDSX as of Q2 2026.

  • Cetera Investment Advisers reported no remaining Biodesix position as of Q2 2026 after selling out during the quarter.
  • Cetera Investment Advisers sold 12,000 Biodesix shares in Q2 2026, an estimated $174K.
  • Cetera Investment Advisers first reported a position in Biodesix in Q1 2024 and held it in 6 quarters.
  • Cetera Investment Advisers's Biodesix position peaked at $174K in Q1 2026.
  • 45 funds tracked by Wall St. Rank held Biodesix as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.